Your browser doesn't support javascript.
loading
General Versus Nongeneral Anesthesia for Middle Meningeal Artery Embolization for Chronic Subdural Hematomas: Multicenter Propensity Score Matched Study.
Salem, Mohamed M; Sioutas, Georgios S; Khalife, Jane; Kuybu, Okkes; Caroll, Kate; Nguyen Hoang, Alex; Baig, Ammad A; Salih, Mira; Khorasanizadeh, Mirhojjat; Baker, Cordell; Mendez, Aldo A; Cortez, Gustavo; Abecassis, Zachary A; Rodriguez, Juan F Ruiz; Davies, Jason M; Narayanan, Sandra; Cawley, C Michael; Riina, Howard A; Moore, Justin M; Spiotta, Alejandro M; Khalessi, Alexander A; Howard, Brian M; Hanel, Ricardo; Tanweer, Omar; Tonetti, Daniel A; Siddiqui, Adnan H; Lang, Michael J; Levy, Elad I; Kan, Peter; Jovin, Tudor; Grandhi, Ramesh; Srinivasan, Visish M; Ogilvy, Christopher S; Gross, Bradley A; Jankowitz, Brian T; Thomas, Ajith J; Levitt, Michael R; Burkhardt, Jan-Karl.
Afiliación
  • Salem MM; Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Sioutas GS; Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Khalife J; Department of Neurosurgery, Cooper University Health Care, Camden, New Jersey, USA.
  • Kuybu O; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Caroll K; Department of Neurosurgery, University of Washington, Seattle, Washington, USA.
  • Nguyen Hoang A; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Baig AA; Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Salih M; Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, Massachusetts, USA.
  • Khorasanizadeh M; Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, Massachusetts, USA.
  • Baker C; Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.
  • Mendez AA; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Cortez G; Department of Cerebrovascular and Endovascular Surgery, Baptist Neurological Institute and Lyerly Neurosurgery, Jacksonville, Florida, USA.
  • Abecassis ZA; Department of Neurosurgery, University of Washington, Seattle, Washington, USA.
  • Rodriguez JFR; Department of Neurosurgery, University of Washington, Seattle, Washington, USA.
  • Davies JM; Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Narayanan S; Departments of Neurology and Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Cawley CM; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Riina HA; Department of Neurosurgery, NYU Langone Medical Center, New York, New York, USA.
  • Moore JM; Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, Massachusetts, USA.
  • Spiotta AM; Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Khalessi AA; Department of Neurosurgery, University of California-San Diego, La Jolla, California, USA.
  • Howard BM; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hanel R; Department of Cerebrovascular and Endovascular Surgery, Baptist Neurological Institute and Lyerly Neurosurgery, Jacksonville, Florida, USA.
  • Tanweer O; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Tonetti DA; Department of Neurosurgery, Cooper University Health Care, Camden, New Jersey, USA.
  • Siddiqui AH; Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Lang MJ; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Levy EI; Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Kan P; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
  • Jovin T; Department of Neurosurgery, University of Texas Medical Branch, Galveston, Texas, USA.
  • Grandhi R; Department of Neurosurgery, Cooper University Health Care, Camden, New Jersey, USA.
  • Srinivasan VM; Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.
  • Ogilvy CS; Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Gross BA; Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, Massachusetts, USA.
  • Jankowitz BT; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Thomas AJ; Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
  • Levitt MR; Department of Neurosurgery, Cooper University Health Care, Camden, New Jersey, USA.
  • Burkhardt JK; Department of Neurosurgery, University of Washington, Seattle, Washington, USA.
Neurosurgery ; 2024 Feb 27.
Article en En | MEDLINE | ID: mdl-38412228
ABSTRACT
BACKGROUND AND

OBJECTIVES:

The choice of anesthesia type (general anesthesia [GA] vs nongeneral anesthesia [non-GA]) in middle meningeal artery embolization (MMAE) procedures for chronic subdural hematomas (cSDH) differs between institutions and left to care team discretion given lack of standard guidelines. We compare the outcomes of GA vs non-GA in MMAE.

METHODS:

Consecutive patients receiving MMAE for cSDH at 14 North American centers (2018-2023) were included. Clinical, cSDH characteristics, and technical/clinical outcomes were compared between the GA/non-GA groups. Using propensity score matching (PSM), patients were matched controlling for age, baseline modified Rankin Scale, concurrent/prior surgery, hematoma thickness/midline shift, and baseline antiplatelet/anticoagulation. The primary end points included surgical rescue and radiographic success rates (≥50% reduction in maximum hematoma thickness with minimum 2 weeks of imaging). Secondary end points included technical feasibility, procedural complications, and functional outcomes.

RESULTS:

Seven hundred seventy-eight patients (median age 73 years, 73.2% male patients) underwent 956 MMAE procedures, 667 (70.4%) were non-GA and 280 were GA (29.6%). After running 13 PSM algorithm, this resulted in 153 and 296 in the GA and non-GA groups, respectively. There were no baseline/procedural differences between the groups except radial access more significantly used in the non-GA group (P = .001). There was no difference between the groups in procedural technical feasibility, complications rate, length of stay, surgical rescue rates, or favorable functional outcome at the last follow-up. Subsequent 11 sensitivity PSM retained the same results. Bilateral MMAE procedures were more performed under non-GA group (75.8% vs 67.2%; P = .01); no differences were noted in clinical/radiographic outcomes between bilateral vs unilateral MMAE, except for longer procedure duration in the bilateral group (median 73 minutes [IQR 48.3-100] vs 54 minutes [39-75]; P < .0001). Another PSM analysis comparing GA vs non-GA in patients undergoing stand-alone MMAE retained similar associations.

CONCLUSION:

We found no significant differences in radiological improvement/clinical outcomes between GA and non-GA for MMAE.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurosurgery Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurosurgery Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...